Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Annual Report & Accounts and Notice of AGM

3rd Mar 2014 07:00

RNS Number : 2627B
Sphere Medical Holding plc
03 March 2014
 



3 March 2014

 

Sphere Medical Holding plc

2013 Annual Report & Accounts and Notice of AGM

 

 

Cambridge, UK, 3 March 2014: Sphere Medical Holding plc (AIM: SPHR.L), ("Sphere" or "Sphere Medical" or the "Company") a leading developer of innovative monitoring and diagnostic devices for the critical care setting, announces that it has published its Annual Report and Accounts for the year ended 31 December 2013. The document will be available later today on the Company's website: www.spheremedical.com.

Sphere Medical confirms that its Annual General Meeting will be held at 11.00am on Friday, 28 March 2014 at Harston Mill, Harston, Cambridge CB22 7GG. The Annual General Meeting Notice is set out in the Annual Report and Accounts.

 

For further information, please contact:

 

Sphere Medical Holding plc

Tel: +44 (0)1223 875 222

Dr. Anthony Martin, Non-Executive Chairman

Dr. Wolfgang Rencken, Chief Executive Officer

Matthew Hall, Chief Financial Officer

Peel Hunt LLP

Tel: +44 (0) 20 7418 8900

James Steel

Clare Terlouw

Jock Maxwell Macdonald

finnCap

Tel: +44 (0) 20 7220 0500

Geoff Nash / Simon Hicks

Stephen Norcross

Consilium Strategic Communications

 

Tel: +44 (0) 20 7920 2333

[email protected]

Mary-Jane Elliott

Amber Bielecka

Matthew Neal

Ivar Milligan

 

Notes for Editors

Sphere Medical (AIM: SPHR.L), is a medical device company developing a range of innovative monitoring and diagnostic devices designed to significantly improve patient care.

 

Sphere Medical's products deliver real time analysis of blood gases, electrolytes and drug levels with laboratory accuracy, at the patient's bedside. Sphere Medical's products can be used in a wide range of medical applications, enabling faster clinical decision making and improved patient outcomes, whilst reducing costs for healthcare payers.

 

Sphere Medical has entered into a collaboration agreement entered with Ortho-Clinical Diagnostics, Inc. for the development of Proxima and enhancement of Sphere's operational and production capabilities.

 

Sphere Medical has a number of partnerships with industry leading medical device companies and has received strategic investments from Johnson & Johnson Development Corporation and Sorin Group.

 

For further information, please visit www.spheremedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWSVRSBAUUAR

Related Shares:

Sphere Medical Holding
FTSE 100 Latest
Value8,415.25
Change0.00